Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21466 AL 21480

Association between variant amyloid deposits and motor deficits in FAD-associated presenilin-1 mutations: A systematic review

Zhang S, Lei C, Liu P, Zhang M, Tao W, Liu H, Liu M.

Neurosci Biobehav Rev. 2015 Sep;56:180-92. doi: 10.1016/j.neubiorev.2015.07.003. Epub 2015 Jul 10.

Changes in gait variability with anti-dementia drugs: a systematic review and meta-analysis

Beauchet O, Launay CP, Allali G, Annweiler C.

CNS Drugs. 2014 Jun;28(6):513-8. doi: 10.1007/s40263-014-0170-6.

Progressive supranuclear palsy finally has a clinically measureable τ abnormality

Halliday G.

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):241. doi: 10.1136/jnnp-2014-308567. Epub 2014 Jul 21.

Sleep and Alzheimer's disease

Peter-Derex L, Yammine P, Bastuji H, Croisile B.

Sleep Med Rev. 2015 Feb;19:29-38. doi: 10.1016/j.smrv.2014.03.007. Epub 2014 Apr 3.

Alzheimer disease and type 2 diabetes mellitus: the link to tyrosine hydroxylase and probable nutritional strategies

Aliev G, Shahida K, Gan SH, Firoz C, Khan A, Abuzenadah AM, Kamal W, Kamal MA, Tan Y, Qu X, Reale M.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):467-77. doi: 10.2174/18715273113126660153.

Neuropathology of parkinsonism in patients with pure Alzheimer's disease

Horvath J, Burkhard PR, Herrmann FR, Bouras C, Kövari E.

J Alzheimers Dis. 2014;39(1):115-20. doi: 10.3233/JAD-131289.

An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies

Kasahata N, Hagiwara M, Kato H, Nakamura A, Uchihara T.

J Alzheimers Dis. 2014;39(3):471-6. doi: 10.3233/JAD-131508.

Lateralized cortical involvement and contralateral parkinsonism without basal ganglia involvement in two autopsy cases of corticobasal syndrome-Alzheimer's disease

Homma T, Takubo H, Takahashi K, Matsubara S, Takahashi M, Funata N, Mochizuki Y, Mizutani T, Komori T, Uchihara T.

J Alzheimers Dis. 2014;40(1):51-5. doi: 10.3233/JAD-131676.

Immunochemical detection of lipid hydroperoxide- and aldehyde-modified proteins in diseases

Sugiyama A, Sun J.

Subcell Biochem. 2014;77:115-25. doi: 10.1007/978-94-007-7920-4_10.

Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: a preliminary perspective

Pal A, Kumar A, Prasad R.

Biometals. 2014 Feb;27(1):25-31. doi: 10.1007/s10534-013-9702-7. Epub 2014 Jan 17.

Gene therapy and cell reprogramming for the aging brain: achievements and promise

Pardo J, Morel GR, Astiz M, Schwerdt JI, León ML, Rodríguez SS, Hereñú CB, Goya RG.

Curr Gene Ther. 2014 Feb;14(1):24-34. doi: 10.2174/1566523214666140120121733.

Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease

Overk CR, Masliah E.

Biochem Pharmacol. 2014 Apr 15;88(4):508-16. doi: 10.1016/j.bcp.2014.01.015. Epub 2014 Jan 21.

Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses

Ibáñez K, Boullosa C, Tabarés-Seisdedos R, Baudot A, Valencia A.

PLoS Genet. 2014 Feb 20;10(2):e1004173. doi: 10.1371/journal.pgen.1004173. eCollection 2014 Feb.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias